Atlas Trials

Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease

Clinical trial NCT05552287 · RECRUITING

Trial details

NCT number
NCT05552287
Sponsor
Erasmus Medical Center
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Crohn DiseaseChild, OnlyBiologic; Inadequate
Start date
2023-08-02
Primary completion
2025-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.